How Arca keeps each patient on the treatment plan.
Arca reads the records your network already produces, checks each patient in treatment against the plan, and sends anything that falls behind to the person who can fix it. The step closes when the record shows the care happened.
- Oncology consultAug 4
- Prior auth approvedAug 6
- Port placedAug 11
- Cycle 1Aug 18
- Cycle 2Due Sep 1Missed · Sep 1Rebooked · Sep 3
- Cycle 3Sep 15
- Restaging CTOct 27
Patient missed cycle 2. Call and rebook.
Patient called · ride arranged · cycle 2 rebooked for Sep 3
One current picture of each cancer episode.
EHR feeds, referrals, authorizations, and clinical records come together for each patient in treatment. AI reads the notes, pathology, and imaging reports, so nobody assembles the chart by hand, and every fact keeps a link to the document it came from.
Arca checks each episode against the plan and the evidence.
Treatment plans are compared with current clinical guidelines and published research, so Arca knows what should have happened by now and what is missing.
A missed infusion, a test the guidelines call for, or an ED visit during chemotherapy marks the patient as needing action, with the evidence attached. Clinicians make the decisions.
Each gap goes to the person who can close it.
Your team decides who owns each kind of gap and how fast it needs handling. Arca assigns it with the plan and the missing step attached, and escalates it to the program lead if the time passes.
A call logged is progress. The gap closes when the infusion, scan, or visit appears in the record, so the program's numbers count care that happened.
An example routing. Each program sets its own.
Each role sees its part of the same episode.
Oncologists
A current summary of each patient, pathway status against the guidelines, and the decisions waiting for them. The clinical decisions stay with the oncologist.
Care teams
Navigators, nurses, and care managers see their own tasks with the plan and the missing step attached, due dates, and anything that has escalated.
Health plans
Pathway status, open care gaps, and treatment starts across the delegated population, months before the claims. The same figures export for accreditation.
Further reading.
Research papers on what treatment delay costs, what Medicare pays for coordination, and what a program should measure. Every figure is sourced.
What Medicare pays for it, what the staffed version returned, and where the avoidable spend sits.
Whitepaper · 7 pages→For Medicare Advantage plansOncology in Medicare AdvantageWhat an MA plan sees at prior authorization, what the 2026 rules change, and where the avoidable spend sits in the months after the decision.
Whitepaper · 10 pages→For self-funded employersCancer as the top employer health costFive years of employer surveys, the clinical price of a delay, and four measures a benefits team can ask its administrators for each quarter.
Whitepaper · 10 pages→Tell us where your oncology risk sits.
Which contracts, which sites, and who manages the follow-through today. We reply within two business days with how Arca would run alongside them, starting with one program.